Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Torild Garen
Observed names:
T Garen,
T. Garen
Institution:
Oslo University Hospital
Observed institutions:
Oslo University Hospital,
University of Oslo
OpenAlex ID:
A5111020931
Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality--a retrospective study based on registry data
2012
·
O. Palm
, T. Garen
, et al.
·
Rheumatology
·
203
Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature
2013
·
R. Gunnarsson
, A. K. Andreassen
, et al.
·
Rheumatology
·
81
High prevalence of inclusion body myositis in Norway; a population‐based clinical epidemiology study
2014
·
G. C. Dobloug
, E. A. Antal
, et al.
·
European Journal of Neurology
·
76
Prevalence of systemic sclerosis in south-east Norway
2012
·
A.-M. Hoffmann-Vold
, O. Midtvedt
, et al.
·
Rheumatology
·
54
High incidence and prevalence of systemic lupus erythematosus in Norway
2012
·
K Lerang
, I Gilboe
, et al.
·
Lupus
·
44
Patients with non-Sjögren’s sicca report poorer general and oral health-related quality of life than patients with Sjögren’s syndrome: a cross-sectional study
2020
·
B. Tashbayev
, T. Garen
, et al.
·
Scientific Reports
·
40
PDF
Efficacy of rehabilitation for patients with ankylosing spondylitis: Comparison of a four-week rehabilitation programe in a Mediteranean and a Norwegian setting
2011
·
YA Staalesen Strumse
, BY Nordvåg
, et al.
·
Journal of Rehabilitation Medicine
·
38
The efficacy of rehabilitation for patients with rheumatoid arthritis: comparison between a 4‐week rehabilitation programme in a warm and a cold climate
2008
·
Y. A. Staalesen Strumse
, B‐Y. Nordvåg
, et al.
·
Scandinavian Journal of Rheumatology
·
31
OP0129 Mycophenolate mofetil versus cyclophosphamide in scleroderma-related interstitial lung disease in a real life scenario
2017
·
H Fretheim
, Ø Midtvedt
, et al.
·
Annals of the Rheumatic Diseases
·
3
PDF
Op0256 Efficacy of Fecal Microbiota Transplantation on Frequency of Fecal Incontinence Symptoms in Systemic Sclerosis Patients With Moderate to Severe Lower Gastrointestinal Disease
2024
·
C. Nita
, H. Fretheim
, et al.
·
Annals of the Rheumatic Diseases
·
2
Pos1472 Accuracy of Disease-specific Icd-10 Code for Incident Systemic Lupus Erythematosus; Results From a Population-based Cohort Study Set in Norway
2023
·
S.R. Moe
, H. Haukeland
, et al.
·
Annals of the Rheumatic Diseases
·
2
PDF
Op0174 Subclinical Interstitial Lung Disease Is Frequent and Progresses Across Different Connective Tissue Diseases
2021
·
A.M. Hoffmann-Vold
, H. Andersson
, et al.
·
Annals of the Rheumatic Diseases
·
2
PDF
O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway
2024
·
Sigrid R Moe
, Hilde Haukeland
, et al.
·
Lupus Science & Medicine
·
1
PDF
Op0255 Igg4-related Disease Activity Assessment Influenced by Use of 18f-fdg Pet/ct: Data From a Norwegian Cohort
2023
·
J. Vikse
, Ø. Midtvedt
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Pos0122 Investigation of Serum Marker Levels in Connective Tissue Diseases Developing Ild
2023
·
H. Didriksen
, H. Fretheim
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Pos0065 Interstitial Lung Disease Associated With Primary Sjögren's Syndrome Is Frequently Progressive
2022
·
A.M. Hoffmann-Vold
, H. Fretheim
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Sat0269 Takayasu Arteritis and Inflammatory Bowel Disease. Coexistence Among Norwegian Patients
2020
·
Ø. Palm
, B. Gudbrandsson
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Thu0348 Altered Immune Recognition of Specific Gut Bacteria by Immunoglobulins in Early Systemic Sclerosis
2020
·
A.M. Hoffmann-Vold
, K. Andréasson
, et al.
·
Annals of the Rheumatic Diseases
·
1
Sat0637-hpr Impaired Health-related Quality of Life and Physical Function in Norwegian Patients With Takayasu Arteritis.
2020
·
T. Garen
, Ø. Palm
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
FRI0257 Augmented Concentrations of Cx3cl1 Are Associated with Progressiv Interstitial Lung Disease in Systemic Sclerosis
2016
·
A.-M. Hoffmann-Vold
, R. Huynh
, et al.
·
Annals of the Rheumatic Diseases
·
1
POS0220 MILDER ILD WITH PRESERVED LUNG FUNCTION SIGNIFICANTLY CONTRIBUTES TO RESPIRATORY CAUSED MORTALITY IN SSc
2024
·
A.M. Hoffmann-Vold
, H. Fretheim
, et al.
·
Annals of the Rheumatic Diseases
Ab1548-hpr Systemic Sclerosis Patients Without Severe Organ Involvement Have a Significant Reduced Health State Compared to the General Population
2024
·
T. Garen
, C. Nita
, et al.
·
Annals of the Rheumatic Diseases
Pos0413-hpr Exercise Capacity by the 6mwd in a Prospective Rmd-ild Cohort Followed Over 12 Months; Impact of Disease Characteristics and Patient Reported Measures
2024
·
M.L. Ramsli
, T. Garen
, et al.
·
Annals of the Rheumatic Diseases
POS0196 DISEASE BURDEN AND IMPACT OF FECAL INCONTINENCE IN SYSTEMIC SCLEROSIS - DATA FROM THE RANDOMIZED ReSScue TRIAL
2024
·
C. Nita
, H. Fretheim
, et al.
·
Annals of the Rheumatic Diseases
Op0252 One-year Trajectories of Diffusion Capacity of Carbon Monoxide as Potential Markers of Outcome in Systemic Sclerosis Associated Pulmonary Hypertension
2024
·
H. Fretheim
, H.J. Bjørkekjær
, et al.
·
Annals of the Rheumatic Diseases
Show more works
View as search
Works count:
51
Citation count:
584
H-index:
8
I10-index:
8
Year
Topic
Type
